In brief: Revelstoke recaps AOM, Vivos to make buy, state legislation makes tracks
By HME News Staff
Updated 10:29 AM CDT, Fri April 18, 2025
DENVER – Revelstoke Capital Partners, a health care-focused private equity firm, has completed a recapitalization of AOM Infusion, a specialty infusion provider of chronic therapy management.
AOM Infusion provides patients with intravenous immunoglobulin, biologics and other therapies, addressing more than 80 different chronic conditions, with long-term treatment administered by skilled infusion nurses. The company also provides support services, including skilled infusion nursing administration, pharmacy services, referral management, insurance verification and patient education and training.
“AOM is committed to growth that enhances patient care,” said Keyur Mehta, CEO of AOM. “We are excited about the new partnership with Revelstoke, and we look forward to extending our reach by expanding our therapeutic focus areas, deepening our clinical expertise and ensuring that patients receive the highest quality infusion therapy in the most comfortable and cost-effective care settings.”
AOM is the ninth investment from Revelstoke Capital Partners Fund III.
Terms of the transaction were not disclosed.
About AOM: The company was founded in 1994 and holds pharmacy licenses in all 50 states.
About Revelstoke: The firm has about $4.8 billion of assets under management. Since its inception in 2013, it has completed 195 acquisitions, which include 30 platform companies and 165 add-on acquisitions.
Vivos to acquire sleep center
LITTLETON, Colo. - Vivos Therapeutics has signed a definitive agreement to acquire The Sleep Center of Nevada for up to $9 million.
The deal includes $6 million in cash, $1.5 million in Vivos common stock at closing, and potential additional $1.5 million in stock tied to performance milestones.
SCN, founded in 2008, is the largest sleep center in Nevada, with approximately 3,000 new patients each month. It operates seven locations with nearly 50 beds for overnight sleep testing.
“We believe this transaction will be a game-changer for Vivos, with the prospect of meaningfully adding to our revenues in the coming months through SCN’s diagnostic and other services as well as adding thousands of patients as candidates for Vivos OSA treatment,” said Kirk Huntsman, chairman and CEO of Vivos. “SCN has a dominant market share for OSA detection and treatment in the fast-growing Las Vegas region. We anticipate SCN patients will prefer Vivos treatment options over a lifelong maintenance device such as CPAP.”
Significant Vivos investor New Seneca Partners, Inc., a leading North American private equity sponsor, assisted in sourcing, structuring and executing this transaction. The acquisition is expected to close in the later this quarter or in the third quarter, subject to financing, audit and other customary conditions.
Aeroflow Health launches diabetes management program
ASHEVILLE, N.C. – Aeroflow Health has launched its Comprehensive Diabetes Management Program, an integrated, multimodal support program that provides patients with the tools and resources to manage their glucose levels The program incorporates a Diabetes Self Management Education (DSME) system designed to provide patients with medication adherence, lifestyle modifications, and glucose monitoring strategies, along with a digital tool to help patients derive meaningful insights from their care, and Medical Nutrition Therapy (MNT). “In the four short years since its inception, Aeroflow Diabetes has expanded to become the leading source of education, services and equipment for those with diabetes,” said Casey Hite, CEO of Aeroflow Health. “The launch of this all-encompassing program for our diabetes patients is a testament to our commitment to improving the long-term health outcomes for our patients. By aligning ourselves with advanced digital tools, including artificial intelligence, and complying with today’s HEDIS standards, we’re continuing our mission to deliver a holistic and patient-centered approach to diabetes care.” Through the program, patients are able to stay on track with their health goals by accessing continuous engagement with doctors and personalized care plans, while health plans are able to stratify risk and engage members more effectively to ensure appropriate care pathways. This is possible through the integration of a new AI-powered digital health tool that syncs patients and their providers with CGM data, allowing for personalized insights, AI-driven coaching, and open communication between provider and patient.
AAHomecare state round up: Ark., S.C., Fla.
Arkansas has enacted legislation to limit the application of step therapy or “fail first” protocols by insurance companies for patients who have been prescribed non-invasive ventilators (NIV). HB 1321 was passed by both chambers of the Arkansas legislature and enacted by Governor Sarah Huckabee on Apr. 10 … On Apr. 9, legislation to broaden the sales tax exemption for HME in South Carolina was reported out of the House Ways & Means Committee in the state legislature. H 3800 now moves to the full House; Senate companion bill S 0266 passed the Sales and Income Tax Subcommittee of the Senate Finance Committee on Apr. 15. Kim Cannan from Hawthorne Medical, treasurer of SCMESA, testified on behalf the legislation at the Apr. 15 session … Bills to restore access to continuous glucose monitors (CGMs) through HME suppliers for Medicaid beneficiaries are moving forward in the Florida legislature. The state had moved GCM coverage exclusively to the pharmacy channel effective Jan. 1 of this year. HB 1465 passed the Health Care Facilities & Systems Subcommittee in March and the Health Care Budget Subcommittee on Apr. 15. A Senate companion, SB 1182, passed the Health Policy Committee in early April and the Appropriations Committee on Health and Human Services on Apr. 15.
Arkansas passes bill to prohibit PBM ownership of pharmacies
ALEXANDRIA, Va. – Arkansas Gov. Sarah Huckabee Sanders on April 16 signed into law, HB legislation that prohibits state permits to pharmacies owned by pharmacy benefit managers effective Jan. 1, 2026. The Arkansas Pharmacists Association worked to advance the bill. “Today is a new day in Arkansas for our patients as the fox will no longer guard the henhouse,” said John Vinson, APA’s CEO. “This bipartisan legislation passed overwhelmingly to protect public health and safety for Arkansans. HB 1150 will stop the abusive self-dealing at PBM affiliated pharmacies that raises prescription drug prices and limits patient access. The National Community Pharmacists Association supported the APAP during the process. “Time and time again, PBMs have proven themselves to be resistant to transparency and reform,” said Anne Cassity, NCPA’s senior vice president of government affairs. “HB 1150 is a structural change that gets to the heart of the problem – the conflicts of interest inherent in vertical integration that PBMs have been manipulating to the detriment of patients, taxpayers, and pharmacies. We applaud HB 1150 and are eager to see its provisions implemented in Arkansas and, ideally, throughout the country.” Since the introduction of HB 1150, similar ownership provisions were introduced or amended into bills in Indiana, New York, Texas, and Vermont. Additionally, on April 14, a bipartisan coalition of 39 state and territory attorneys general sent a letter to congressional leaders urging them to pass legislation prohibiting PBMs from owning or operating pharmacies.
Blackstone Medical, EnsoData partner on home sleep testing
MADISON, Wis. – Blackstone Medical Services (BMS), a Medicare-approved, JCAHO-accredited and nationally recognized IDTF for home sleep testing, has partnered with EnsoData, an innovator in AI healthtech solutions, to offer improved accessibility to diagnosis and treatment for the millions of patients currently living with undiagnosed sleep apnea. BMS leverages EnsoData’s FDA-cleared, EnsoSleep PPG home sleep testing solution to equip primary care physicians with an effective and efficient method to reach patients suffering with sleep disorders. By simplifying the identification, diagnosis, and treatment of sleep-related conditions, BMS is helping accelerate patient care, improve patient outcomes, and reduce healthcare costs. “Our partnership with EnsoData allows us to provide an affordable, accessible at-home solution that is paving the way for fast, accurate diagnoses and better health outcomes nationwide,” said Vick Tipnes, Blackstone Medical CEO. Many patients face significant barriers in accessing healthcare, particularly those who live in rural or underserved areas, say the companies. “As sleep medicine evolves, the role of accessible technology has never been more critical,” said Justin Mortara, Ph.D., EnsoData CEO. “EnsoSleep PPG provides BMS with an avenue to reach more patients, no matter their location or ability to visit traditional sleep labs.”
Synapse taps Singh as president
SKOKIE, Ill. – Synapse Health has appointed Mandira Singh as president. Singh joined Synapse in August as a senior adviser. Previously, she served as senior partner and chief platform officer at Habitat Health, a joint venture with Kaiser Permanente in PACE, focused on elder care and vulnerable patients. Before that, she was head of product and chief operating officer of Collective Medical; upon its acquisition by PointClickCare, she was named senior vice president and general manager for the acute and payer business, where she focused on driving growth for more than 1,000 hospitals and every national health plan in the U.S. “Mandira has a real talent for building tech products that integrate seamlessly with services to foster collaboration and provide improved experiences for stakeholders throughout the healthcare ecosystem,” said Cory Roberts, co-founder and CEO of Synapse Health. “Her rare skill set and proven success growing health tech companies into industry leaders is a boon to our work as we invest in AI and other emerging tech to drive efficiency for the benefit of all in the DME space.” In February, Synapse tapped former AdaptHealth exec Shaw Rietkerk as COO.
HME Home Health marks successful first year for E-Store
RICHMOND, B.C. – HME Home Health is marking the one-year anniversary of the launch of its HME E-Store, which has processed more than 2,500 orders. “To me as a leader in technology in the medical distribution space being one of the first companies in Canada to offer online shopping for customers in British Columbia and Alberta,” said Robert Boscacci, co-founder and CEO. “Our e-commerce results have been exceptional with our team processing for 3700 product invoices in just the past 12 months.” The e-store is completely integrated with the company’s seven warehouses, ensuring all products ship within 48 hours. The platform also offers a live chat feature and allows sales teams and therapists to share shopping carts with families, eliminating the back-and-forth of quotes.
- Related: E-Store paves way for future expansion.
DocNow launches telehealth platform
BELLEVUE, Wash. – DocNow, a provider of electronic health record (EHR) solutions for post-acute care, has launched DocNow Telehealth, a secure, Zoom-powered virtual care platform built specifically for providers in skilled nursing facilities, long-term care and home health settings. DocNow Telehealth enables providers to conduct virtual visits directly within the DocNow EHR environment—eliminating the need for separate systems and reducing administrative burden. "Virtual care is no longer optional—it's an essential part of delivering timely, effective post-acute care," said Dr. Kashif Saeed, CEO of DocNow. "We built DocNow Telehealth to meet the specific needs of our customers: fast, secure, and integrated. It's not just a video tool, it's a workflow solution."
Key Features of DocNow Telehealth
- HIPAA-compliant video visits: Secure, high-quality video and audio powered by Zoom
- Integrated scheduling & documentation: Embedded directly into existing DocNow workflows
- Scalable across organizations: Supports both small groups and large enterprise teams
- Real-time communication: Enables coordination before, during, and after visits
- Usage analytics: Provides insight into encounters, and clinical impact.
Comments